Gerald F Watts is a senior consultant physician, full professor and chair of The Familial Hypercholesterolaemia-Australasia Network. He trained at Imperial and King’s Colleges in the University of London before moving to Australia. He is currently lead of the Cardiometabolic Service (Departments of Cardiology and Internal Medicine) and Professor of Cardiometabolic Medicine at the Royal Perth Hospital and the University of Western Australia. Research interests include lipid disorders, obesity and cardiovascular prevention, and clinical interests focus on delivering improved care for FH and related conditions. Professor Watts is actively involved in teaching and supervises several MD and PhD students and post-doctoral fellows. He has authored over 700 published works and is on the editorial board of Atherosclerosis, Clinical Science, Metabolism, Journal of Clinical Lipidology, American Journal of Preventative Cardiology, Current Opinion in Lipidology, and Current Opinion in Endocrinolgy, Obesity and Diabetes.

Dr. Watts makes the following disclosures:  Honoria/Expenses:  Amgen, Kowa, MSD, Sanofi, Regeneron, AstraZeneca, Novartis.  Consulting/Advisory Board:  Amgen, Sanofi, Regeneron, AstraZeneca.  Funded Research:  Amgen, Sanofi, Regeneron, Novartis